Dirceu Barbano confirmed as head of Anvisa
This article was originally published in SRA
Dirceu Br�s Aparecido Barbano has been confirmed as director-president of the Brazilian healthcare products regulatory agency Anvisa (Agência Nacional de Vigilância Sanit�ria). He has held this role in a caretaker capacity since January, when his predecessor, clinical analyst Dirceu Raposo de Mello, stepped down after six years at the helm. Mr Barbano joined the Brasilia-based agency as a director in October 2008, with a background specialising in pharmacy.
You may also be interested in...
Recommending new medicines for approval and allowing sponsors of others extra time to answer outstanding questions are among the many tasks on the agenda of the March meeting of European Medicines Agency's key scientific committee, the CHMP. The meeting has been taking place, remotely, this week.
If Zolgensma gets the thumbs up from the EMA this week, it will likely get formal EU approval within a couple of months.
BMS should find out mid-2020 whether its new MS drug will be approved in the EU.